Plus: JetBlue CEO eyes more growth in Boston; AG Andrea Campbell offers fiery words about Trump; Charles River chamber offers ...

Andrew Baum, Pfizer's chief strategy and innovation officer, talked Thursday about the pharmaceutical company's drug ...

Ignota Labs is using AI to fix failed drugs and bring them to market. It raised $6.9 million from investors with this pitch ...

With decades of experience in pharmaceutical development and extensive genetic medicine expertise, Doug E. Williams, Ph.D., and Murray Stewart, ...

John "Chip" Scarlett, who as chairman, president and CEO repositioned Geron Corp. and guided the company to its first drug ...

March 11, 2025 /PRNewswire/ -- Apnimed, Inc., a pharmaceutical company focused ... clinical and future commercial successes." At Longboard, Mr. Lind also led the initiation of a global Phase ...

Apnimed, Inc., a pharmaceutical company focused on discovering, developing, and commercializing first-in-class oral therapies for the neuromuscular dysfunction associated with obstructive sleep apnea ...

Nissan said Tuesday that Ivan Espinosa, its chief planning officer, would take the helm from April 1, ending weeks of speculation over who will succeed Makoto Uchida as leader of the troubled ...

Abzena, a San Diego-based CDMO and CRO focused on bioconjugates and complex biologics, has welcomed Taylor Boyd as its new ...

TOKYO -- Swiss pharmaceutical company Novartis has pegged ... looking to make it "at least a $10 billion business" over the next decade, CEO Vasant Narasimhan told Nikkei in an interview.

CTT Pharma's CEO will issue a news release to shareholders this Wednesday March 12, 2025. About CTT Pharmaceuticals Holdings, Inc. CTT has patented technology in the United States, Europe ...